In a groundbreaking development, results from a recent clinical trial to treat lung cancer show that a novel immunotherapy combination is surprisingly effective at controlling the disease's progression.
Something has gone wrong. Please try again.
New to The Surg?
Sign up now to get your own personalized science feed!